KBC Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $186M | Buy |
|
|||||
|
2025
Q1 | $235M | Sell |
|
|||||
|
2024
Q4 | $229M | Buy |
|
|||||
|
2024
Q3 | $177M | Sell |
|
|||||
|
2024
Q2 | $233M | Buy |
|
|||||
|
2024
Q1 | $287M | Buy |
|
|||||
|
2023
Q4 | $146M | Buy |
|
|||||
|
2023
Q3 | $85.9M | Sell |
|
|||||
|
2023
Q2 | $138M | Buy |
|
|||||
|
2023
Q1 | $104M | Sell |
|
|||||
|
2022
Q4 | $129M | Sell |
|
|||||
|
2022
Q3 | $201M | Sell |
|
|||||
|
2022
Q2 | $239M | Buy |
|
|||||
|
2022
Q1 | $221M | Buy |
|
|||||
|
2021
Q4 | $171M | Buy |
|
|||||
|
2021
Q3 | $161M | Sell |
|
|||||
|
2021
Q2 | $340M | Buy |
|
|||||
|
2021
Q1 | $290M | Buy |
|
|||||
|
2020
Q4 | $1.47B | Buy |
|
|||||
|
2020
Q3 | $206M | Buy |
|
|||||
|
2020
Q2 | $180M | Buy |
|
|||||
|
2020
Q1 | $47M | Sell |
|
|||||
|
2019
Q4 | $60.5M | Buy |
|
|||||
|
2019
Q3 | $44.3M | Buy |
|
|||||
|
2019
Q2 | $38.4M | Buy |
|
|||||
|
2019
Q1 | $35.2M | Buy |
|
|||||
|
2018
Q4 | $21.7M | Buy |
|
|||||
|
2018
Q3 | $25M | Buy |
|
|||||
|
2018
Q2 | $20M | Sell |
|
|||||
|
2018
Q1 | $23.6M | Buy |
|
|||||
|
2017
Q4 | $19.7M | Sell |
|
|||||
|
2017
Q3 | $30.1M | Buy |
|
|||||
|
2017
Q2 | $23.5M | Sell |
|
|||||
|
2017
Q1 | $46.9M | Buy |
|
|||||
|
2016
Q4 | $18.9M | Sell |
|
|||||
|
2016
Q3 | $18.8M | Sell |
|
|||||
|
2016
Q2 | $38.4M | Buy |
|
|||||
|
2016
Q1 | $24.8M | Buy |
|
|||||
|
2015
Q4 | $24.4M | Sell |
|
|||||
|
2015
Q3 | $23.9M | Sell |
|
|||||
|
2015
Q2 | $32M | Buy |
|
|||||
|
2015
Q1 | $28.2M | Sell |
|
|||||
|
2014
Q4 | $34.1M | Buy |
|
|||||
|
2014
Q3 | $8.16M | Sell |
|
|||||
|
2014
Q2 | $26.2M | Sell |
|
|||||
|
2014
Q1 | $38.3M | Buy |
|
|||||
|
2013
Q4 | $36.3M | Sell |
|
|||||
|
2013
Q3 | $36.1M | Buy |
|
|||||
|
2013
Q2 | $23.3M | Buy |
|